Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill version of Novo Nordisk's ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...

With more than half a million Australians now taking drugs like Ozempic and Mounjaro every month, Senior Kolling Institute researcher, Professor Sarah Glastras, has called for a shift away from the ...

But a new Oxford University study published in The BMJ suggests the benefits may be short-lived. Researchers found that people tend to regain weight quickly after discontinuing weight-loss medications ...

In an emotional video, actress and comedian Mo'Nique urged her fans to consider the dangers of using a GLP-1 for weight loss.

Losing weight should ­herald the beginning of a new life of better health and fitness. But coming off weight-loss jabs or an ...

Mounjaro is a self-administered injection which received regulatory approval for the treatment of type 2 diabetes and chronic ...

Emma Dyer says she collapsed on her bathroom floor and began vomiting blood after buying jabs online.

UF veterinary professor Dr. Chen Gilor is leading a large pilot study of a GLP-1 weight loss drug called MEOW-1, or ...

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs. Federal regulators are seeking to rein in the online telemedicine platform ...

Serena Williams’ weight-loss drug use sparks a moral dilemma ahead of rumoured tennis comeback - IN DEPTH: The 23-time grand slam winner reentered the anti-doping testing pool, making herself eligible ...